59 related articles for article (PubMed ID: 23766517)
1. Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls antioxidant transcriptional responses and viability of cancer cells.
Ziros PG; Manolakou SD; Habeos IG; Lilis I; Chartoumpekis DV; Koika V; Soares P; Kyriazopoulou VE; Scopa CD; Papachristou DJ; Sykiotis GP
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1422-7. PubMed ID: 23766517
[TBL] [Abstract][Full Text] [Related]
2. NFE2-Related Transcription Factor 2 Coordinates Antioxidant Defense with Thyroglobulin Production and Iodination in the Thyroid Gland.
Ziros PG; Habeos IG; Chartoumpekis DV; Ntalampyra E; Somm E; Renaud CO; Bongiovanni M; Trougakos IP; Yamamoto M; Kensler TW; Santisteban P; Carrasco N; Ris-Stalpers C; Amendola E; Liao XH; Rossich L; Thomasz L; Juvenal GJ; Refetoff S; Sykiotis GP
Thyroid; 2018 Jun; 28(6):780-798. PubMed ID: 29742982
[TBL] [Abstract][Full Text] [Related]
3. Targeting Nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract][Full Text] [Related]
4. Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer.
Renaud CO; Ziros PG; Chartoumpekis DV; Bongiovanni M; Sykiotis GP
Front Endocrinol (Lausanne); 2019; 10():510. PubMed ID: 31428048
[TBL] [Abstract][Full Text] [Related]
5. Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.
Martinez VD; Vucic EA; Pikor LA; Thu KL; Hubaux R; Lam WL
Mol Cancer; 2013 Oct; 12(1):124. PubMed ID: 24138990
[TBL] [Abstract][Full Text] [Related]
6. Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
Chartoumpekis DV; Sykiotis GP
N Engl J Med; 2014 May; 370(18):1767. PubMed ID: 24785221
[No Abstract] [Full Text] [Related]
7. The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway.
He L; Zhang T; Sun W; Qin Y; Wang Z; Dong W; Zhang H
Med Oncol; 2020 Oct; 37(11):97. PubMed ID: 33001278
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention.
Wu R; Zhang J; Zou G; Li S; Wang J; Li X; Xu J
Diabetes Metab Syndr Obes; 2024; 17():809-823. PubMed ID: 38380275
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the link between thyroid cancer and mercury exposure: a review and meta-analysis.
Webster AM; Pinion D; Pineda E; Aboueisha H; Hussein MH; Fawzy MS; Toraih EA; Kandil E
Environ Sci Pollut Res Int; 2024 Feb; 31(9):12841-12855. PubMed ID: 38273084
[TBL] [Abstract][Full Text] [Related]
10. Inositol polyphosphate multikinase modulates redox signaling through nuclear factor erythroid 2-related factor 2 and glutathione metabolism.
Tyagi R; Chakraborty S; Tripathi SJ; Jung IR; Kim SF; Snyder SH; Paul BD
iScience; 2023 Jul; 26(7):107199. PubMed ID: 37456841
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma.
Wang Z; Li J; Liu Z; Yue L
Eur J Histochem; 2023 Mar; 67(2):. PubMed ID: 36951264
[TBL] [Abstract][Full Text] [Related]
12. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
Li W; Huang G; Wei J; Cao H; Jiang G
Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
[TBL] [Abstract][Full Text] [Related]
13. The Cross-Talk between Polyphenols and the Target Enzymes Related to Oxidative Stress-Induced Thyroid Cancer.
Heydarzadeh S; Kia SK; Zarkesh M; Pakizehkar S; Hosseinzadeh S; Hedayati M
Oxid Med Cell Longev; 2022; 2022():2724324. PubMed ID: 35571253
[TBL] [Abstract][Full Text] [Related]
14. The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer.
Gong Z; Xue L; Wei M; Liu Z; Vlantis AC; van Hasselt CA; Chan JYK; Li D; Zeng X; Tong MCF; Chen GG
Oxid Med Cell Longev; 2021; 2021():3900330. PubMed ID: 34527171
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA XIST inhibits osteoblast differentiation and promotes osteoporosis via Nrf2 hyperactivation by targeting CUL3.
Chen X; Ma F; Zhai N; Gao F; Cao G
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34036379
[TBL] [Abstract][Full Text] [Related]
16. The Keap1/Nrf2 Signaling Pathway in the Thyroid-2020 Update.
Thanas C; Ziros PG; Chartoumpekis DV; Renaud CO; Sykiotis GP
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33158045
[TBL] [Abstract][Full Text] [Related]
17. The Transcriptomic Response of the Murine Thyroid Gland to Iodide Overload and the Role of the Nrf2 Antioxidant System.
Chartoumpekis DV; Ziros PG; Georgakopoulos-Soares I; Smith AAT; Marques AC; Ibberson M; A Kopp P; Habeos I; Trougakos IP; Khoo NKH; Sykiotis GP
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32961913
[TBL] [Abstract][Full Text] [Related]
18.
Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
[TBL] [Abstract][Full Text] [Related]
19. Mice Hypomorphic for
Ziros PG; Renaud CO; Chartoumpekis DV; Bongiovanni M; Habeos IG; Liao XH; Refetoff S; Kopp PA; Brix K; Sykiotis GP
Thyroid; 2021 Jan; 31(1):23-35. PubMed ID: 32689903
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
